Compounded Semaglutide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

WARNING

Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

• Severe nausea and/or vomiting resulting in dehydration—it is important to stay well hydrated and drink plenty of fluids while on this medication
  Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis
• Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below)
• Pancreatitis: Severe pain in your abdomen or back that will not go away
• Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
• Hepatitis/Elevated liver enzymes/Jaundice
• Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy
• Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
• Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
• Increasing heart rate
• Worsening depression, behavior changes, or suicidality

Never share the semaglutide with other people

Drug Interactions

As with other medications, compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded semaglutide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded semaglutide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

To report suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

In case of emergencies, please call 911 or go to the nearest emergency room.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

BLACK BOX WARNING

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

If you experience a medical emergency, call 911 or go to the nearest emergency room.

Tell your healthcare provider about your medical history prior to taking semaglutide.

Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting semaglutide, as your diabetes medications may need to be adjusted as you lose weight.

Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.

Notify your doctor if you have kidney, liver, or pancreas problems.

Stop using semaglutide and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.

Stop using semaglutide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.

Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue semaglutide if suspected and promptly seek medical advice.

‍

Compounded Tirzepatide

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing tirzepatide are available.

WARNING

Compounded tirzepatide usage has been associated with the potential development of thyroid tumors, including thyroid cancer. Watch for any potential symptoms, such as neck lumps or swelling, hoarseness, difficulty swallowing, or breathlessness. Should any of these symptoms arise, it is imperative to inform your healthcare provider promptly.

Avoid using compounded tirzepatide if you or any family members have a history of medullary thyroid carcinoma (MTC), a specific type of thyroid cancer. Similarly, refrain from its use if diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you've previously experienced a severe allergic reaction to tirzepatide or any of its components.

Serious Side Effects

Compounded tirzepatide carries the risk of severe side effects, which include:

• Gastrointestinal Issues: Reports indicate the possibility of severe stomach problems associated with compounded tirzepatide usage. Notify your healthcare provider if you experience persistent or severe stomach discomfort.
• Kidney Complications: Diarrhea, nausea, and vomiting may lead to dehydration, potentially resulting in kidney problems. Adequate fluid intake is crucial to mitigate this risk.
• Gallbladder Concerns: Some individuals may encounter gallbladder problems while using compounded tirzepatide. Seek immediate medical attention if symptoms such as upper abdominal pain, fever, jaundice, or changes in stool color occur.
• Pancreatitis: Discontinue use and contact your healthcare provider if you experience persistent abdominal pain, with or without vomiting, as it could indicate inflammation of the pancreas.
• Allergic Reactions: Cease compounded tirzepatide usage and seek urgent medical assistance if you develop symptoms of a severe allergic reaction, including facial swelling, breathing difficulties, rash, or rapid heartbeat.
• Hypoglycemia: The risk of low blood sugar may increase when using compounded tirzepatide alongside medications that lower blood sugar levels. Recognizable symptoms include dizziness, sweating, confusion, and rapid heartbeat.
• Vision Changes: Notify your healthcare provider of any alterations in vision observed during tirzepatide treatment.
• Depression or Suicidal Thoughts: Pay close attention to changes in mood or mental state while using tirzepatide, and promptly report any concerns to your healthcare provider.

Common Side Effects

The most frequently reported side effects of compounded tirzepatide include:

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Abdominal pain
• Indigestion
• Injection site reactions
• Fatigue
• Allergic reactions
• Belching
• Hair loss
• Heartburn

These side effects are not exhaustive. Should you experience any persistent or bothersome side effects, discuss them with your healthcare provider for appropriate management.

Tell your healthcare provider if you have any side effects.

To report suspected severe side effects or adverse reactions to compounded trizepatide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergencies, please call 911 or go to the nearest emergency room.

Drug Interactions

As with other medications, compounded trizepatide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Compounded trizepatide delays gastric emptying and may impact the absorption of oral medications. If you are on papillary hormone medication, prior to starting compounded trizepatide, please review the timing of taking your papillary hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on compounded trizepatide.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

Tirzepatide may alter the efficacy of birth control pills. Talk with your doctor before starting tirzepatide if you are on birth control. Your healthcare provider may recommend another type of birth control for 4 weeks after you start tirzepatide and for 4 weeks after each increase in your dose.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

‍

NAD+ Injection: Important Safety Information

1. Introduction

Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme found in all living cells, involved in critical metabolic processes. NAD+ injections are sometimes used for various wellness purposes. Please note that NAD+ injections may not be evaluated or approved by the U.S. Food and Drug Administration (FDA) for safety, effectiveness, or quality. If you have any questions about NAD+ therapy, consult a qualified healthcare professional.

2. Purpose & Benefits

• NAD+ may be administered for potential support of energy metabolism, cellular repair, or other wellness goals.
• This information does not constitute medical advice regarding indications or dosage and is provided for educational purposes only.

3. Contraindications

You should not receive NAD+ injections if you:

• Have a known allergy or hypersensitivity to NAD+ or any of the injection components.
• Are pregnant, planning to become pregnant, or breastfeeding, unless specifically advised by your healthcare provider.
• Have severe or unstable medical conditions (e.g., uncontrolled diabetes, end-stage renal disease, significant heart or liver disease) without first consulting a physician.

4. Potential Risks & Side Effects

While many individuals tolerate NAD+ injections well, side effects can occur. Contact your healthcare provider immediately if any symptoms worsen or become unmanageable. Potential side effects include:

1. Injection Site Reactions
   
   • Redness, swelling, or pain at the injection site.
   • Bruising or minor bleeding.
   • ‍
2. Gastrointestinal Disturbances
   
   • Nausea, vomiting, or diarrhea.
   • Abdominal discomfort or cramping.
   • ‍
3. Headache or Dizziness
   
   • May occur shortly after injection.
   • If severe or persistent, seek medical attention.
4. ‍
5. Changes in Energy Levels
   
   • Some individuals report fatigue or jitteriness, especially if combined with other stimulants.
6. ‍
7. Allergic Reactions
   
   • Rash, itching, swelling (including of the face, lips, tongue, or throat), or difficulty breathing.
   • Seek emergency care if you suspect a serious allergic reaction (anaphylaxis).

5. Warnings & Precautions

1. Not FDA-Approved
   ‍
2. ‍
   • NAD+ injections have not been evaluated by the FDA for safety or efficacy.
   • If you prefer FDA-approved treatments, discuss alternatives with your healthcare provider.
3. ‍
4. Medical Supervision Required
   
   • NAD+ injections should be administered by a qualified healthcare professional or under professional guidance, following all recommended safety protocols.
5. ‍
6. Pre-Existing Conditions
   
   • Inform your healthcare provider of any heart, kidney, liver, or other medical conditions.
   • Discuss any concerns regarding potential interactions with existing medications or supplements.
7. ‍
8. Use in Specific Populations
   
   • Safety and effectiveness in children have not been established.
   • Pregnant or nursing women should consult a physician before use.
9. ‍
10. Monitor for Unusual Symptoms
    
    • Report any unexpected changes in mood, behavior, or physical health (e.g., extreme fatigue, chest pain, shortness of breath).

6. Drug Interactions

• NAD+ may interact with certain prescription or over-the-counter medications, herbal supplements, or dietary regimens.
• Tell your healthcare provider about all medications and supplements you take before starting NAD+ injections.
• Watch for potential changes in how other medications work, as NAD+ could theoretically affect metabolic pathways.

7. Administration & Dosage

1. Administration Method
   
   • Typically administered intramuscularly (IM) or Subcutaneous (SUBQ) under medical supervision.
   • Proper aseptic technique is critical to minimize risks of infection or injection site complications.
2. Dosage
   
   • The appropriate dose varies based on individual factors (age, weight, underlying health conditions).
   • Follow the dosage and schedule as prescribed by your healthcare provider.
   • Do not self-adjust or discontinue injections without consulting your provider.

8. Reporting Adverse Events

• If you experience concerning side effects or a serious adverse event, seek immediate medical care.
• You can also report suspected adverse reactions to the FDA’s MedWatch Program at 1-800-FDA-1088 or at www.fda.gov/medwatch.

9. Additional Precautions & Tips

• Hydration: Staying well-hydrated may help mitigate some side effects like headaches or dizziness.
• Lifestyle Factors: Aim for a balanced diet, regular exercise, and healthy sleep to optimize any potential benefits of NAD+ therapy.
• Follow-Up: Schedule follow-up appointments or lab tests if your healthcare provider deems them necessary to monitor any changes while on NAD+ therapy.

10. Disclaimer

• These statements have not been evaluated by the Food and Drug Administration.
• NAD+ injections are not intended to diagnose, treat, cure, or prevent any disease.
• This document is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

For questions or concerns about NAD+ injections, potential benefits, or side effects, please consult a qualified healthcare provider.

‍

Sermorelin: Important Safety Information

1. Introduction

• What is Sermorelin?
  Sermorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH). It works by stimulating the pituitary gland to produce and secrete natural growth hormone (GH).
  
  
• Regulatory Status
  Sermorelin may be prescribed or compounded by certain healthcare providers but may not be approved by the U.S. Food and Drug Administration (FDA) for all uses. If you prefer only FDA-approved medications for your condition, please consult your healthcare provider for alternatives.
  
  

2. Potential Benefits & Indications

• Common Uses
  Some practitioners use sermorelin to help address growth hormone deficiencies, promote lean body mass, support energy levels, or assist with certain aspects of aging.
• Limitations
  The efficacy of sermorelin for anti-aging or athletic performance enhancement is not conclusively established in large-scale clinical trials. This product is not intended to diagnose, treat, cure, or prevent any disease beyond those conditions specifically recognized by your healthcare professional.

3. Contraindications

You should not use sermorelin if you:

• Have an active malignancy, especially related to the pituitary gland or hypothalamus.
• Have a known hypersensitivity or allergy to sermorelin or any of its components.
• Are pregnant, planning to become pregnant, or breastfeeding, unless advised otherwise by a qualified healthcare professional.
• Have severe or unstable medical conditions (e.g., uncontrolled diabetes, advanced kidney or liver disease) without close medical supervision.

4. Warnings & Precautions

1. ‍
2. Not FDA-Approved for All Uses
   
   • Sermorelin may be used off-label for certain conditions. Its safety and efficacy for those uses are not fully evaluated by the FDA.
3. ‍
4. Consult a Healthcare Professional
   
   • Provide your full medical history to your healthcare provider before starting sermorelin.
   • Discuss any other medications, supplements, or therapies you are using, as these can impact sermorelin’s efficacy or risk profile.
5. ‍
6. Pre-Existing Conditions
   
   • If you have diabetes, thyroid disorders, or any endocrine-related condition, careful monitoring may be needed because sermorelin can affect hormone balance.
7. ‍
8. Use in Specific Populations
   
   • The safety of sermorelin in children, pregnant women, or nursing mothers has not been thoroughly established outside of specific medical indications.
   • Use only under professional guidance if you belong to these populations.

5. Potential Side Effects

Contact your healthcare provider if any symptoms become severe or do not resolve:

1. Injection Site Reactions
   
   • Redness, pain, swelling, or itching at the site of injection.
   • If signs of infection (e.g., warmth, pus, significant tenderness) occur, seek medical attention.
2. ‍
3. Flushing or Headaches
   
   • Some people may experience flushing, mild headaches, or lightheadedness.
   • If headaches are persistent or severe, discontinue use and consult your healthcare provider.
4. ‍
5. Nausea or Dizziness
   
   • Occasional nausea or dizziness can occur.
   • Discontinue and speak with a healthcare provider if these symptoms worsen or persist.
6. ‍
7. Increased Hunger
   
   • A change in appetite or mild GI discomfort may be noticed.
8. ‍
9. Allergic Reactions
   
   • Rash, hives, swelling of the face, lips, tongue, or throat, or difficulty breathing may signal a serious allergic reaction.
   • Seek immediate medical care if anaphylaxis is suspected.

6. Drug Interactions

• Other Medications/Supplements
  • Sermorelin may interact with medications that influence the endocrine system, glucose metabolism, or other peptides/hormones.
  • Always inform your healthcare provider about all prescription, over-the-counter medications, and supplements you use.

7. Administration & Dosage

1. ‍
2. Administration Method
   
   • Typically administered as a subcutaneous (under the skin) injection.
   • Injections should be performed as directed by a qualified healthcare professional or according to detailed instructions provided.
3. ‍
4. Dosage
   
   • Dosage and frequency vary based on individual factors such as age, body weight, and treatment goals.
   • Do not exceed prescribed dosage without consulting your healthcare provider.
5. ‍
6. Timing & Technique
   
   • Your healthcare provider may advise specific timing (e.g., bedtime) to optimize the natural growth hormone cycle.
   • Proper injection technique is essential to minimize side effects and ensure effectiveness.

8. Monitoring & Follow-up

• Lab Tests
  • Your healthcare provider may recommend periodic blood tests (e.g., IGF-1 levels) to monitor hormone levels and treatment response.
• Physical Check-ups
  • Regular check-ups may be necessary to track weight, body composition, or other health indicators.

9. Storage & Handling

• Storage
  • Store sermorelin according to the temperature guidelines provided on the label or by your pharmacist (often refrigerated).
• Shelf Life
  • Do not use beyond the expiration date. Discard if the product changes color or appears contaminated.
• Safety
  • Keep all medications out of the reach of children.
  • Never reuse needles or syringes; follow proper disposal instructions.

10. Adverse Event Reporting

• Severe Reactions
  • Discontinue use and seek immediate medical attention if you experience severe or unusual side effects.
• FDA Reporting
  • You or your healthcare provider can report suspected adverse reactions to the FDA’s MedWatch Program at 1-800-FDA-1088 or via www.fda.gov/medwatch.

11. Disclaimer

• Not Evaluated by the FDA
  • These statements have not been evaluated by the Food and Drug Administration, and sermorelin is not FDA-approved to diagnose, treat, cure, or prevent any condition outside of recognized uses.
• Consult a Professional
  • This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
• Individual Variation
  • Responses to sermorelin may vary. Always follow the advice of a qualified healthcare provider regarding initiation, continuation, or modification of therapy.

Questions or Concerns?

If you have any questions regarding sermorelin injections, dosage, benefits, or potential side effects, please consult your qualified healthcare provider.

‍

Important Safety Information for Ozempic (semaglutide) injection

Warning: Risk of Thyroid C-Cell Tumors

• In studies with mice and rats, semaglutide (the active ingredient in Ozempic and Wegovy) caused thyroid tumors, including thyroid cancer. It is not known if Ozempic will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
• Do not use Ozempic if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What is the FDA-approved use of Ozempic?

Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist that is used:

• with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
• to reduce the risk of major adverse cardiovascular events in patients with type 2 diabetes mellitus and established cardiovascular disease.

Limitations of Use:

• Ozempic has not been studied in patients with a history of pancreatitis.
• Ozempic is not for treatment of type 1 diabetes mellitus.

Your provider may recommend the use of Ozempic as treatment for chronic weight management (obesity or overweight).

Who should not use Ozempic?

Do not use Ozempic if:

• You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• You have a known allergic reaction to semaglutide (the active ingredient in Wegovy or Ozempic).

How should Ozempic be administered?

You can take Ozempic with or without food. The pre-filled injector pen is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. Your provider will guide you on a treatment regimen that may include an increase in dose every four weeks.

You should not change your dosing regimen or stop taking Ozempic as prescribed without discussing with your provider first.  

What should I tell my provider before using Ozempic?

• Ozempic has certain drug interactions. It’s important to tell your provider all of the medications you are currently taking, including prescription, over-the-counter medications, vitamins, and herbal and dietary supplements.

Some medications to watch out for include:

• Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL)
• Ozempic causes a delay in gastric emptying so it has the potential to impact the absorption of medications that are taken by mouth at the same time. Your provider can guide you on how to schedule your medications.
• Other GLP-1 medications, including Wegovy, Saxenda, Victoza, Byetta, or Bydureon
• If you’re using other products for weight loss, including dietary supplements

It’s important to share your entire medical history with your provider. In particular, tell your provider if you have a past history of:

• Type 1 or type 2 diabetes
• Thyroid cancer
• Pancreatitis
• Kidney disease
• Diabetic retinopathy
• Depression
• Suicidal thoughts or behavior

Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding.

• If you are pregnant: Ozempic should not be used during pregnancy. Based on animal studies, there may be potential risks to an unborn baby from exposure to Ozempic during pregnancy. There is no benefit to weight loss during pregnancy and it may cause harm to the unborn baby.
• If you are a female or male of reproductive potential: Discontinue Ozempic at least 2 months before a planned pregnancy since the drug can stay in the bloodstream for a long time.
• If you are breastfeeding: Ozempic was found in the milk of lactating rats. Tell your provider if you are breastfeeding before you start Ozempic.

Pregnancy registry: There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to semaglutide (the active ingredient in Ozempic and Ozempic) during pregnancy. Pregnant women exposed to semaglutide and healthcare providers are encouraged to contact Novo Nordisk at 1-800-727-6500.

Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.

What are the most serious side effects that I or a caregiver should monitor for when taking Ozempic?

If you are experiencing a medical emergency, call 911 or seek immediate medical attention.

These serious side effects can occur with Ozempic. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.

• Thyroid C-Cell Tumors: In mice and rats, semaglutide (the active ingredient in Ozempic and Ozempic) caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is unknown whether Ozempic causes thyroid C-cell tumors in humans. There were cases of MTC reported in patients who took liraglutide (the active ingredient in Victoza and Saxenda) after the drug was put on the market. Ozempic is contraindicated in patients with a family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
• Inflammation of Pancreas (Acute Pancreatitis): Monitor for signs of acute pancreatitis, including severe abdominal pain that does not go away, sometimes radiating to the back, with or without vomiting.
• Diabetic Retinopathy Complications in Patients with Type 2 Diabetes: If you have type 2 diabetes, tell your provider right away if you experience changes in vision.
• Never Share a Pen: Pen-sharing poses a risk of infection.
• Low Blood Sugar (hypoglycemia): Ozempic lowers blood glucose. It can cause too low blood sugar in patients with type 2 diabetes who also take another glucose control medication. Monitor your blood sugar and watch out for signs of too low blood sugar such as dizziness, blurred vision, mood changes, sweating, or fast heartbeat.
• Acute Kidney Injury: In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink plenty of water to help reduce your chance of dehydration.
• Serious Allergic Reactions: Stop using Ozempic right away if you experience symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, severe rash or itching, very rapid heartbeat, problems breathing or swallowing, or fainting or feeling dizzy.
• Acute Gallbladder Disease: Ozempic may cause gallbladder problems, including gallstones. Some gallbladder problems require surgery. Tell your provider right away if you have pain in your upper stomach, yellowing of skin or eyes (jaundice), fever, or clay-colored stools.
• Increase in Heart Rate: Tell your provider right away if you have a racing heartbeat while at rest.

• Suicidal Behavior and Ideation: You should pay attention to any mental health changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.

What are the most common side effects of Ozempic?

• Nausea
• Vomiting
• Diarrhea
• Stomach pain
• Constipation

You are encouraged to report negative side effects of prescription products:

• Contact Novo Nordisk Inc. at 1-833-934-6891
• Contact FDA MedWatch at 1-800-FDA-1088 or visit www.fda.gov/medwatch

This information is not comprehensive. Please see the full Prescribing Information for complete safety information.

‍

Important Safety Information for Mounjaro® (tirzepatide) Injection

Warning: Risk of Thyroid C-Cell Tumors
Mounjaro® (tirzepatide) injection may cause thyroid tumors, including thyroid cancer. Watch for symptoms such as a lump or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath. If you experience any of these symptoms, inform your healthcare provider immediately.

• Do not use Mounjaro® (tirzepatide) injection if you or any family members have a history of medullary thyroid carcinoma (MTC).
• Do not use if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What is the FDA-approved use of Mounjaro® (tirzepatide) injection?

Mounjaro® (tirzepatide) is an injectable medication approved for adults with type 2 diabetes. It is used alongside diet and exercise to improve blood sugar (glucose) control.

Limitations of Use:

• It is not known if Mounjaro® can be used in people with a history of pancreatitis.
• It is not approved for type 1 diabetes or for use in children under 18 years of age.

Who should not use Mounjaro® (tirzepatide) injection?

Do not use Mounjaro® if:

• You or a family member has a history of medullary thyroid carcinoma (MTC) or MEN 2.
• You are allergic to Mounjaro® or its ingredients.

How should I take Mounjaro® (tirzepatide) injection?

• Take Mounjaro® once weekly, on the same day each week, with or without food.
• Use the pre-filled injector pen as a subcutaneous injection in your stomach, thigh, or upper arm. Rotate injection sites weekly.
• Follow the dosing regimen provided by your WeightMeds provider, which may include dose increases every four weeks.

Do not change or stop your prescribed regimen without consulting your WeightMeds provider. If you take too much Mounjaro®, contact your healthcare provider immediately.

What should I discuss with my WeightMeds provider before starting Mounjaro®?

• Share your full medical history, including any thyroid, gastrointestinal, pancreatic, kidney, or vision issues.
• Discuss all medications, including over-the-counter drugs, supplements, and vitamins, as Mounjaro® may interact with some medications.
• Inform your provider if you are pregnant, planning to become pregnant, or breastfeeding.
• If using oral birth control, switch to a non-oral method or use a barrier method for 4 weeks after starting or increasing your dose of Mounjaro®.

Most Serious Side Effects to Monitor For:

• Thyroid C-Cell Tumors
• Severe Gastrointestinal Issues: Nausea, vomiting, or diarrhea that may worsen pre-existing conditions.
• Pancreatitis: Severe abdominal pain that may radiate to the back.
• Low Blood Sugar (Hypoglycemia): Symptoms include dizziness, sweating, confusion, or rapid heartbeat.
• Allergic Reactions: Swelling, rash, or difficulty breathing.
• Kidney Problems: Dehydration may worsen kidney function.
• Gallbladder Issues: Look for abdominal pain, fever, jaundice, or unusual stools.
• Vision Changes: Particularly if you have diabetic retinopathy.
• Mental Health Changes: Report any suicidal thoughts or mood changes immediately.

Common Side Effects:

• Nausea, vomiting, or diarrhea
• Constipation or indigestion
• Injection site reactions
• Tiredness
• Belching or heartburn

For a full list of side effects and complete safety information, consult the prescribing information.

Disclaimer:
WeightMeds has no affiliation with Novo Nordisk, Eli Lilly, or Amylin Pharmaceuticals. Medications offered by WeightMeds are not manufactured by these companies. Trademarks such as Ozempic®, Wegovy®, and Mounjaro® are owned by their respective manufacturers.

For more information, contact WeightMeds or your healthcare provider.

‍